FADS2 and acute myeloid leukemia: We therefore performed metabolic tracing in AML cells [31] using 13C18-linoleic acid with FADS1/2 or FADS2 pharmacologic inhibitors and observed elongation and desaturation through the ω6 pathway as well as incorporation into the TCA cycle.